Long-term management of patients with end-stage lung diseases.


Long-term management of end-stage lung disease differs from interstitial lung disease to chronic obstructive pulmonary disease to cystic fibrosis to pulmonary vascular disease. The management includes pharmacological therapy that is disease specific such as antibiotic therapy for cystic fibrosis, antifibrotic drugs in idiopathic pulmonary fibrosis; long… (More)
DOI: 10.1016/j.bpa.2017.07.007


Cite this paper

@article{Briganti2017LongtermMO, title={Long-term management of patients with end-stage lung diseases.}, author={Domenica Federica Briganti and Frank D'ovidio}, journal={Best practice & research. Clinical anaesthesiology}, year={2017}, volume={31 2}, pages={167-178} }